Digital Specialty Chemicals Limited (DSC), a dual bottom line corporation and leading provider of advanced materials to the semiconductor, pharmaceutical, and specialty chemical markets, announced that it has received an equity investment from Intel Capital, Intel Corporation’s global investment organization. The investment will enhance the company’s research and development capabilities and will accelerate manufacturing capacity expansion.
DSC specializes in the manufacture of organophosphorus and organometallic chemistries used in both memory and logic thin film atomic layer deposition (ALD) manufacturing processes at leading semiconductor integrated circuit (IC) fabrication sites worldwide. The company is a leader in the manufacturing and handling of both novel specialty chemicals in large volume, high purity air- sensitive chemicals that require nitrogen and vacuum-operated vessels, using high pressure reactors and multiple distillation techniques.
“Since 1987, we have provided custom and high volume high purity chemicals to the semiconductor, pharmaceutical and specialty chemical markets worldwide. Our people, processes and facilities combine to offer the agility of a small, fine- chemical operation with the capacity of a large supplier,” said Dr. Ravi R. Gukathasan, CEO. “We believe that the continuation of Moore’s Law for semiconductor processing will depend greatly on continued innovation of advanced precursors which provides a growth opportunity for DSC. The funding from Intel Capital will help enable us to construct R&D and manufacturing facilities to meet growing demand for thin film technologies.”
“Materials innovation is critical to enabling new capabilities in semiconductor device design and manufacturing,” said Robert Bruck, corporate vice president and general manager of Global Supply Management at Intel. “We look forward to supporting DSC’s growth including development of new materials technologies for advanced semiconductor manufacturing process technology nodes.”